Jiangsu Nhwa Pharmaceutical (002262.SZ) obtains the Rightinoxacin Anfetamine Trinol Injection Drug Registration Certificate.
Enkang Pharmaceutical (002262.SZ) announced that the company recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration for the chemical drug Ketoprofen Am inosulfonic acid Tramadol Injection. Ketoprofen Am inosulfonic acid Tramadol Injection is a non-steroidal anti-inflammatory analgesic, which is an inhibitor of both COX-1 and COX-2 activity. It is used as an adjunct to opioid analgesics for the treatment of acute moderate to severe postoperative pain in adults who are not suitable for oral administration.
Jiangsu Nhwa Pharmaceutical (002262.SZ) announced that the company recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration for the chemical drug Ketorolac Tromethamine Injection. Ketorolac Tromethamine Injection is a non-steroidal anti-inflammatory and analgesic drug, which is an inhibitor of COX-1 and COX-2 activity. It is used as an adjunct to opioid analgesics for postoperative pain in adults who are not suitable for oral administration of medication.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
